Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): Short-term outcomes of a multicenter randomized controlled trial.
Authors
Jianmin Xu
Department of General Surgery, Zhongshan Hospital Fudan University, Shanghai, China
Jianmin Xu , Weitang Yuan , Taiyuan Li , Bo Tang , Baoqing Jia , Yanbing Zhou , Wei Zhang , Ren Zhao , Cheng Zhang , Longwei Cheng , Xiaoqiao Zhang , Fei Liang , Guodong He , Ye Wei , Qingyang Feng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT02817126
DOI
10.1200/JCO.2022.40.4_suppl.014
Abstract #
14
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Short-term outcomes of laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): A multicenter, randomized, controlled trial.
First Author: Pan Chi
Poster
2023 ASCO Breakthrough
The safety of robot-assisted surgery versus laparoscopic surgery for rectal tumor patients.
First Author: Jesse Yu Tajima
Poster
2014 Gastrointestinal Cancers Symposium
Residual rectal cancer after preoperative radiochemotherapy (ypT1-2): An indication for local excision instead of radical surgery?
First Author: Thilo Sprenger
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Applying the fragility index to randomized controlled trials evaluating total neoadjuvant therapy for rectal cancer.
First Author: Tyler McKechnie